MDT - Medtronic plc
| Previous Close | 84.73 |
| Open | 84.54 |
| Bid | 84.22 x 1200 |
| Ask | 84.85 x 800 |
| Day's Range | 82.77 - 84.64 |
| 52 Week Range | 78.29 - 100.15 |
| Volume | 6,739,424 |
| Avg. Volume | 5,676,367 |
| Market Cap | 112.952B |
| Beta (3Y Monthly) | 0.69 |
| PE Ratio (TTM) | 23.78 |
| EPS (TTM) | 3.54 |
| Earnings Date | May 23, 2019 |
| Forward Dividend & Yield | 2.00 (2.20%) |
| Ex-Dividend Date | 2019-03-21 |
| 1y Target Est | 103.28 |
- Investor's Business Daily•yesterday
A Diabetes Treatment Revolution Could Bolster These Medtech Firms
Medical device companies like Abbott, Medtronic and Tandem Diabetes are jockeying for a piece of the diabetes treatment market, which could be worth north of $2 trillion by 2030.
- Thomson Reuters StreetEvents•yesterday
Edited Transcript of MDT earnings conference call or presentation 19-Feb-19 1:00pm GMT
Q3 2019 Medtronic PLC Earnings Call
GlobeNewswire•2 days agoMedtronic Data Expands on Key Aortic Solutions for Challenging Anatomies
April 17, 2019 - Medtronic plc (MDT) today released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant(TM) II/IIs stent graft system in combination with Heli-FX(TM) EndoAnchor(TM) implants and for the Valiant Navion(TM) thoracic stent graft system for thoracic endovascular repair (TEVAR). The data presented at the Charing Cross Symposium in London expands on the commitment to treat increasingly challenging aortic anatomies.
- GlobeNewswire•2 days ago
Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
April 17, 2019 - Medtronic plc (MDT) today announced five-year outcomes from the VeClose Extension Study. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease. The VeClose Extension Study is a follow-on study with the purpose of evaluating long-term outcomes at five years post-treatment with the VenaSeal Closure System.
- Motley Fool•6 days ago
3 Top Diabetes Stocks to Watch in April
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
- Zacks•7 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised)
The outcomes of the study demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- American City Business Journals•9 days ago
Want to fix your own iPhone? Minnesota could be first to pass right to repair laws
Minnesota is one of 19 states that have proposed legislation called Fair Repair. The act, also referred to as Right to Repair in some states, would require electronics manufacturers to make their repair manuals, tools and parts available for purchase by consumers and repair shops.
- Zacks•9 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use
The outcomes of the study, conducted by Medtronic (MDT), demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- Zacks•9 days ago
Medtronic (MDT) Inks Value-Based Deal for Guardian Connect
Medtronic's (MDT) Guardian Connect system can now be accessed via a Blue Cross and Blue Shield of Minnesota member's pharmacy benefit.
- GlobeNewswire•11 days ago
New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System
Positive HVAD LATERAL TM Study Results Also Now Published in The Journal of Heart and Lung Transplantation DUBLIN and ORLANDO, Fla. - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced data showing ...
- Zacks•11 days ago
Medtronic's New Data for HVAD System to Boost CRHF Segment
Medtronic's (MDT) latest data is expected to boost top-line contributions from the HeartWare HVAD System within the CRHF suite.
- GlobeNewswire•11 days ago
New Study Finds Targeted Drug Delivery (TDD) is Associated with a Reduction in Health Care Utilization and Cost for Cancer Pain Patients
Savings Are Driven by Fewer Inpatient Visits, Shorter Inpatient Length of Stay, and Fewer Emergency Department Visits DUBLIN - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced results of a study ...
- GlobeNewswire•14 days ago
Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management
Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes DUBLIN and ORLANDO, Fla. - April 5, 2019 - Medtronic plc (NYSE:MDT) ...
- American City Business Journals•14 days ago
Ecolab joins campaign for LGBTQ Equality Act
Ecolab Inc. is the latest large employer to come out in support of the Equality Act, which would extend federal civil rights protections to lesbian, gay, bisexual, transgender and queer (LGBTQ) employees.
GuruFocus.com•16 days ago6 Poorly Performing Stocks in Gurus' Portfolios
While gurus hold positions in these companies, the share price and returns continue to fall. The company, which refines petroleum products, has a $41.07 billion market cap. The stock is trading with a price-earnings ratio of 11.44.
- Zacks•16 days ago
Nevro (NVRO) Plagued by Issues in Australia & Stiff Rivalry
Nevro's (NVRO) international sales get affected by weakness in Australia.
- Zacks•17 days ago
Medtronic's Diabetes Arm Grows Strong, Rising Costs Ail
Medtronic (MDT) is highly optimistic about its foray into the $1-billion standalone CGM market with its Guardian Connect.
- Zacks•17 days ago
The Zacks Analyst Blog Highlights: Chevron, IBM, Medtronic, lululemon and Carnival
The Zacks Analyst Blog Highlights: Chevron, IBM, Medtronic, lululemon and Carnival
- Zacks•18 days ago
Top Analyst Reports for Chevron, IBM & Medtronic
Top Analyst Reports for Chevron, IBM & Medtronic
- Zacks•23 days ago
Medtronic Unveils MedTech Innovation Accelerator in China
The MedTech Innovation Accelerator is a collaborative initiative on part of Medtronic (MDT) to foray into the Chinese med-tech innovation market via venture investments, incubation and acceleration.
- Insider Monkey•24 days ago
Were Hedge Funds Right About Medtronic, plc (MDT)?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 15 S&P 500 stocks among hedge funds at […]
- American City Business Journals•24 days ago
Medtronic launches med-tech accelerator in Shanghai
Medtronic is launching an accelerator for early-stage medical-technology companies that will be based in Shanghai.
- Simply Wall St.•24 days ago
Read This Before Buying Medtronic plc (NYSE:MDT) Shares
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We've lost count of how many times insiders have accumulatedRead More...
- GlobeNewswire•25 days ago
Medtronic Launches Medtech Innovation Accelerator in Shanghai
March 25, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced the launch of the Medtronic MedTech Innovation Accelerator in Pujiang International Science and Technology City at Minhang District, Shanghai. The new collaborative innovation platform will provide services for MedTech start-ups worldwide, address unmet clinical needs in China, and welcome its initial roster of portfolio companies.
- TechCrunch•28 days ago
Homeland Security warns of critical flaws in Medtronic defibrillators
Homeland Security has issued a warning for a set of critical-ratedvulnerabilities in Medtronic defibrillators that put the devices at risk ofmanipulation
